Slowdown in OTC sector

Influenced by a compulsory bioequivalence testing requirements dictated by the government this year, the number of newly approved ethicals during August-October period stood at 712, or 90 percent of the 770 items while that of OTCs stood at 34, taking a toll on the domestic pharmaceutical industry.

The Korea Food and Drug Administration said the less portion of OTCs in newly approve...